Starpharma Holdings Ltd SPL-AU:ASX

*Data is delayed | Exchange | AUD
Last | 11:36 AM AET
0.115quote price arrow down-0.005 (-4.17%)
Volume
267,023
52 week range
0.10 - 0.47
Loading...
  • Open0.12
  • Day High0.12
  • Day Low0.115
  • Prev Close0.12
  • 52 Week High0.47
  • 52 Week High Date05/19/23
  • 52 Week Low0.10
  • 52 Week Low Date05/03/24

Key Stats

  • Market Cap32.79M
  • Shares Out411.8M
  • 10 Day Average Volume739,768.44
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change-32.35

KEY STATS

  • Open0.12
  • Day High0.12
  • Day Low0.115
  • Prev Close0.12
  • 52 Week High0.47
  • 52 Week High Date05/19/23
  • 52 Week Low0.10
  • 52 Week Low Date05/03/24
  • Market Cap32.79M
  • Shares Out411.8M
  • 10 Day Average Volume739,768.44
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change-32.35

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-5.18
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Starpharma Holdings Ltd

 

Profile

MORE
Starpharma Holdings Limited is an Australia-based biopharmaceutical company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical, life-science and other applications. It is focused on developing and commercializing novel therapeutic products that address global healthcare needs. The Company is also involved in the development of nano-scale materials, including the development of VivaGel for...
Robert Thomas
Independent Non-Executive Chairman of the Board
Cheryl Maley
Chief Executive Officer, Managing Director, Director
Justin Cahill
Chief Financial Officer, Joint Company Secretary
Jeremy Paull Ph.D.
Vice President - Development and Regulatory Affairs
Address
4-6 Southampton Crescent, Abbotsford
Melbourne, VIC
3067
Australia